Pharmaceutical advertising versus research spending: are profits more important than patients?
Open Access
- 31 October 2003
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 146 (4) , 563-564
- https://doi.org/10.1016/s0002-8703(03)00399-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart diseaseThe Lancet, 2002
- Coxibs supplement: has CCJM sold out?Cleveland Clinic Journal of Medicine, 2002
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Direct-to-Consumer Advertising — Education or Emotion Promotion?New England Journal of Medicine, 2002
- Promotion of Prescription Drugs to ConsumersNew England Journal of Medicine, 2002
- Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: an observational cohort studyThe Lancet, 2002
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary ArteriesCirculation, 2001
- Physician motivations for nonscientific drug prescribingSocial Science & Medicine, 1989
- Advertising: Informational but Not EducationalNew England Journal of Medicine, 1972